Key result
Dexmedetomidine sedation during AF ablation cuts respiratory disturbance index by ~43% vs thiamylal.
Why the study?
Procedural sedation by non-anaesthesiologists with GABAergic anaesthetics carries a risk of fatal respiratory depression, and dexmedetomidine may offer safer sedation during AF ablation.
Does dexmedetomidine improve respiratory safety and patient immobility compared to thiamylal during ablation of atrial fibrillation?
Comparison
Dexmedetomidine vs thiamylal as procedural sedatives during AF ablation
Design
Randomized controlled trial
Follow-up
During the procedure
Authors
Loading...
May favor dexmedetomidine for sedation in AF ablation to reduce respiratory events; extends RCT options for safer procedural sedation in electrophysiology.
RCT (n=87)
randomized
Does dexmedetomidine improve respiratory safety and patient immobility compared to thiamylal during ablation of atrial fibrillation?
Absolute Event Rate: 10.4% vs 18.2%
p-value: p=< 0.0001
Dexmedetomidine provides a safer respiratory profile and better patient immobility compared to thiamylal during AF ablation, although rescue sedation is frequently required.
Sairaku et al. (2013) conducted an RCT in Atrial fibrillation (n=87). Dexmedetomidine vs. Thiamylal was evaluated on Respiratory disturbance index (RDI) (p=< 0.0001). Procedural sedation with dexmedetomidine during atrial fibrillation ablation significantly reduced the respiratory disturbance index compared to thiamylal (10.4 vs. 18.2 events/h; P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: